Position in BIOA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$569,612
New position
Shares Held
23,240
first reported quarter
Ownership
0.051%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#89
of 151 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in BIOA
reported options exposure · as of Jun 30, 2026CallValue
$1,838,250
CallShares
75,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $32,819,609 across 14 Drug Manufacturers - Specialty & Generic names. BIOA ranks #11 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
258,331 | $8,752,254 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
9,333 | $5,056,899 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
29,500 | $4,971,930 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
40,000 | $3,311,200 | |
| 5 | PRGO |
PERRIGO Co plc
|
253,459 | $2,633,439 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
25,000 | $1,598,750 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
197,863 | $1,567,074 | |
| 8 | EOLS |
Evolus, Inc.
|
216,316 | $1,501,233 |
All Filings in BIOA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,838,250 | 75,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $569,612 | 23,240 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||